Blue Owl Capital Holdings LP's Q4 2024 13F: 11 new positions, 69 exits
Form 13F-HR for the quarter ended Dec 31, 2024 · filed Feb 14, 2025 · 78 reported positions · accession 0000950123-25-002412
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Exited | PROSHARES TR (TQQQ) | 4.6% | — | −4.6 pts | −325K sh | −100% |
| Reduced | TOURMALINE BIO INC (TRML) | 7.6% | 5.0% | −2.6 pts | −451K sh | −29% |
| Increased | CONDUENT INC (CNDT) | 2.6% | 5.2% | +2.6 pts | +2.26M sh | +67% |
| New | ELEDON PHARMACEUTICALS INC (ELDN) | — | 1.9% | +1.9 pts | +1.96M sh | new |
| New | TANGO THERAPEUTICS INC (TNGX) | — | 1.2% | +1.2 pts | +1.73M sh | new |
| New | EYEPOINT PHARMACEUTICALS INC (EYPT) | — | 1.1% | +1.1 pts | +668K sh | new |
| Reduced | KLAVIYO INC (KVYO) | 8.2% | 10.3% | +2.0 pts | −120K sh | −10% |
| Exited | LANZATECH GLOBAL INC (LNZA) | 1.1% | — | −1.1 pts | −2.93M sh | −100% |
| Increased | CULLINAN THERAPEUTICS INC (CGEM) | 6.5% | 6.7% | +0.1 pts | +360K sh | +18% |
| Exited | CCC INTELLIGENT SOLUTIONS HL (CCC) | 1.0% | — | −1.0 pts | −457K sh | −100% |
| Exited | STARWOOD PROPERTY TRUST (STWD) | 0.9% | — | −0.9 pts | −226K sh | −100% |
| Reduced | DISC MEDICINE INC (IRON) | 1.7% | 1.8% | +0.1 pts | −55,000 sh | −31% |
| Exited | PYXIS ONCOLOGY INC (PYXS) | 0.8% | — | −0.8 pts | −1.13M sh | −100% |
| Reduced | PLIANT THERAPEUTICS INC (PLRX) | 6.5% | 8.4% | +1.9 pts | −235K sh | −8% |
| Exited | JANUX THERAPEUTICS INC (JANX) | 0.7% | — | −0.7 pts | −80,000 sh | −100% |
| New | PALVELLA THERAPEUTICS INC NE (PVLA) | — | 0.7% | +0.7 pts | +250K sh | new |
| Exited | STRUCTURE THERAPEUTICS INC (GPCR) | 0.6% | — | −0.6 pts | −65,000 sh | −100% |
| Exited | BRAZE INC (BRZE) | 0.5% | — | −0.5 pts | −78,222 sh | −100% |
| Exited | MINERALYS THERAPEUTICS INC (MLYS) | 0.5% | — | −0.5 pts | −196K sh | −100% |
| Exited | IMMUNOVANT INC (IMVT) | 0.4% | — | −0.4 pts | −80,000 sh | −100% |
| Increased | KEROS THERAPEUTICS INC (KROS) | 1.4% | 0.9% | −0.5 pts | +120K sh | +98% |
| Reduced | ULTRAGENYX PHARMACEUTICAL IN (RARE) | 1.8% | 1.1% | −0.6 pts | −45,000 sh | −28% |
| Increased | LARIMAR THERAPEUTICS INC (LRMR) | 5.3% | 4.1% | −1.1 pts | +486K sh | +12% |
| New | MARKER THERAPEUTICS INC (MRKR) | — | 0.4% | +0.4 pts | +554K sh | new |
| Reduced | SAGIMET BIOSCIENCES INC (SGMT) | 0.9% | 1.4% | +0.5 pts | −350K sh | −21% |
| Increased | HOLLEY INC (HLLY) | 1.5% | 2.1% | +0.6 pts | +447K sh | +18% |
| Reduced | AQUESTIVE THERAPEUTICS INC (AQST) | 1.2% | 0.7% | −0.4 pts | −325K sh | −27% |
| Exited | BLEND LABS INC (BLND) | 0.3% | — | −0.3 pts | −362K sh | −100% |
| Exited | PAYONEER GLOBAL INC (PAYO) | 0.3% | — | −0.3 pts | −208K sh | −100% |
| Exited | NU HLDGS LTD (NU) | 0.2% | — | −0.2 pts | −91,324 sh | −100% |
| Increased | CONTEXT THERAPEUTICS INC (CNTX) | 2.1% | 1.5% | −0.5 pts | +947K sh | +17% |
| Exited | SYROS PHARMACEUTICALS INC (SYRS) | 0.2% | — | −0.2 pts | −516K sh | −100% |
| Increased | ENGENE HOLDINGS INC (ENGN) | 3.9% | 4.8% | +0.9 pts | +101K sh | +3% |
| New | REZOLVE AI LTD (RZLV) | — | 0.2% | +0.2 pts | +182K sh | new |
| Exited | PROSHARES TR II (UVXY) | 0.1% | — | −0.1 pts | −30,000 sh | −100% |
| Reduced | MEREO BIOPHARMA GROUP PLC (MREO) | 0.7% | 0.5% | −0.1 pts | −175K sh | −21% |
| New | COMPASS PATHWAYS PLC (CMPS) | — | 0.1% | +0.1 pts | +161K sh | new |
| Reduced | CENTESSA PHARMACEUTICALS PLC (CNTA) | 0.8% | 0.8% | +0.1 pts | −35,000 sh | −14% |
| New | GITLAB INC (GTLB) | — | 0.1% | +0.1 pts | +10,076 sh | new |
| Reduced | ENGENE HOLDINGS INC (ENGNW) | 0.1% | 0.0% | −0.1 pts | −475K sh | −93% |
| Exited | DESKTOP METAL INC (DM) | 0.1% | — | −0.1 pts | −750K sh | −100% |
| Reduced | AEON BIOPHARMA INC (AEON) | 0.7% | 0.4% | −0.3 pts | −292K sh | −9% |
| Exited | PRECISION BIOSCIENCES INC (DTIL) | 0.0% | — | 0.0 pts | −20,220 sh | −100% |
| Exited | PIPER SANDLER COMPANIES (PIPR) | 0.0% | — | 0.0 pts | −607 sh | −100% |
| New | SYNTEC OPTICS HLDGS INC (OPTX) | — | 0.0% | 0.0 pts | +49,575 sh | new |
| Reduced | INOZYME PHARMA INC (INZY) | 1.1% | 0.7% | −0.4 pts | −40,000 sh | −4% |
| Increased | COMPASS THERAPEUTICS INC (CMPX) | 1.0% | 1.0% | 0.0 pts | +75,000 sh | +3% |
| New | ALPHA MODUS HLDGS INC (AMODW) | — | 0.0% | 0.0 pts | +1.19M sh | new |
| Increased | REPARE THERAPEUTICS INC (RPTX) | 2.2% | 1.0% | −1.2 pts | +71,160 sh | +2% |
| Exited | GERON CORPORATION (GERN) | 0.0% | — | 0.0 pts | −23,918 sh | −100% |
The 50 largest of 105 changes, by size of the trade. Full holdings for this quarter.
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 71.5% of the equity book
Changes in the top 10 this quarter: CNDT entered · TQQQ left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | NUVEEN CHURCHILL DIRECT LEND (NCDL) | 13.6% | 15.6% | |
| 2 | KLAVIYO INC (KVYO) | 8.2% | 10.3% | |
| 3 | PLIANT THERAPEUTICS INC (PLRX) | 6.5% | 8.4% | |
| 4 | BLUE OWL CAPITAL CORPORATION (OBDC) | 5.8% | 7.1% | |
| 5 | CULLINAN THERAPEUTICS INC (CGEM) | 6.5% | 6.7% | |
| 6 | CONDUENT INC (CNDT) | 2.6% | 5.2% | Entered the top 10 |
| 7 | TOURMALINE BIO INC (TRML) | 7.6% | 5.0% | |
| 8 | ENGENE HOLDINGS INC (ENGN) | 3.9% | 4.8% | |
| 9 | EVERCOMMERCE INC (EVCM) | 3.3% | 4.2% | |
| 10 | LARIMAR THERAPEUTICS INC (LRMR) | 5.3% | 4.1% | |
| — | PROSHARES TR (TQQQ) | 4.6% | 0.0% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).
Option positions (puts and calls)
Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.
| Activity | Security | Type | Shares before | Shares now | Reported value |
|---|---|---|---|---|---|
| Exited | VIKING THERAPEUTICS INC (VKTX) | Call | 41,000 | 0 | $0 |